                         SEQUENCE LISTING

<110>  The Board of Trustees of the University of Illinois
       Aakalu, Vinay
       Jain, Sandeep
 
<120>  METHODS OF USING HISTATIN FOR DIAGNOSING AND TREATING A DRY EYE 
       DISEASE OR OTHER OCULAR DISEASES

<130>  UIC0080WO

<150>  US 62/749,785
<151>  2018-10-24

<160>  12    

<170>  PatentIn version 3.5

<210>  1
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  PHOSPHORYLATION

<400>  1

Asp Ser His Glu Lys Arg His His Gly Tyr Arg Arg Lys Phe His Glu 
1               5                   10                  15      


Lys His His Ser His Arg Glu Phe Pro Phe Tyr Gly Asp Tyr Gly Ser 
            20                  25                  30          


Asn Tyr Leu Tyr Asp Asn 
        35              


<210>  2
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Arg Lys Phe His Glu Lys His His Ser His Arg Glu Phe Pro Phe Tyr 
1               5                   10                  15      


Gly Asp Tyr Gly Ser Asn Tyr Leu Tyr Asp Asn 
            20                  25          


<210>  3
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3

Asp Ser His Ala Lys Arg His His Gly Tyr Lys Arg Lys Phe His Glu 
1               5                   10                  15      


Lys His His Ser His Arg Gly Tyr Arg Ser Asn Tyr Leu Tyr Asp Asn 
            20                  25                  30          


<210>  4
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Lys Phe His Glu Lys His His Ser His Arg Gly Tyr Arg Ser Asn Tyr 
1               5                   10                  15      


Leu Tyr Asp Asn 
            20  


<210>  5
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  5

Asp Ser His Ala Lys Arg His His Gly Tyr Lys Arg Lys Phe His Glu 
1               5                   10                  15      


Lys His His Ser His Arg Gly Tyr 
            20                  


<210>  6
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  6

Asp Ser His Ala Lys Arg His His Gly Tyr Lys Arg Lys Phe His Glu 
1               5                   10                  15      


Lys His His Ser His Arg Gly Tyr Arg 
            20                  25  


<210>  7
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  7

Arg Lys Phe His Glu Lys His His Ser His Arg Gly Tyr 
1               5                   10              


<210>  8
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  8

Lys Phe His Glu Lys His His Ser His Arg Gly Tyr 
1               5                   10          


<210>  9
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Arg Lys Phe His Glu Lys His His Ser His Arg Gly Tyr Arg 
1               5                   10                  


<210>  10
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  10

Lys Phe His Glu Lys His His Ser His Arg Gly Tyr Arg 
1               5                   10              


<210>  11
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  11

Lys Arg His His Gly Tyr Lys Arg 
1               5               


<210>  12
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  12

Lys Arg His His Gly Tyr Lys 
1               5           


